Evidence map›Paper›PMID 23152765›Full record

ArticlePloS one2012

Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach.

Vincent A Emanuele, Gitika Panicker, Brian M Gurbaxani, Jin-Mann S Lin, Elizabeth R Unger

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Proteins are potent biomarkers to detect colon cancer progression.Saudi journal of biological sciences · 2017
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vincent A EmanueleChronic and Viral Diseases Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. VEmanueleII@cdc.gov
Gitika Panicker
Brian M Gurbaxani
Jin-Mann S Lin
Elizabeth R Unger

Funding

SBIR PHASE I TOPIC #177: ENHANCING THE QUALITY OF INTERN43CN005005 · CN · CLINICAL TOOLS, INC. · PI TANNER, T BRADLEY · 2000 to 2000
$100k
HUMAN STUDIES OF DIET AND NUTRITIONZ01CN000101 · CN · CANCER PREVENTION AND CONTROL · PI TAYLOR, PHILIP · 1985 to 2004
–
Intramural NIH HHS Z01 CN000101NCI NIH HHS Y1-CN-0101-01NCI NIH HHS Y1-CN-5005-01
6 · The paper itself

Abstract

SELDI-TOF mass spectrometer's compact size and automated, high throughput design have been attractive to clinical researchers, and the platform has seen steady-use in biomarker studies. Despite new algorithms and preprocessing pipelines that have been developed to address reproducibility issues, visual inspection of the results of SELDI spectra preprocessing by the best algorithms still shows miscalled peaks and systematic sources of error. This suggests that there continues to be problems with SELDI preprocessing. In this work, we study the preprocessing of SELDI in detail and introduce improvements. While many algorithms, including the vendor supplied software, can identify peak clusters of specific mass (or m/z) in groups of spectra with high specificity and low false discover rate (FDR), the algorithms tend to underperform estimating the exact prevalence and intensity of peaks in those clusters. Thus group differences that at first appear very strong are shown, after careful and laborious hand inspection of the spectra, to be less than significant. Here we introduce a wavelet/neural network based algorithm which mimics what a team of expert, human users would call for peaks in each of several hundred spectra in a typical SELDI clinical study. The wavelet denoising part of the algorithm optimally smoothes the signal in each spectrum according to an improved suite of signal processing algorithms previously reported (the LibSELDI toolbox under development). The neural network part of the algorithm combines those results with the raw signal and a training dataset of expertly called peaks, to call peaks in a test set of spectra with approximately 95% accuracy. The new method was applied to data collected from a study of cervical mucus for the early detection of cervical cancer in HPV infected women. The method shows promise in addressing the ongoing SELDI reproducibility issues.

Indexed as

Neural Networks, ComputerAdolescentAdultAgedAlgorithmsBiomarkersCarcinoma in SituCervix MucusFemaleHumansMiddle AgedPrevalenceQuality ControlReproducibility of ResultsSensitivity and SpecificitySoftwareBiomarkers

Identifiers

PMID23152765
PMCPMC3495950

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.